Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theodore Phillips

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Archives of Neurology|October 12, 2005
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectationsElliot M Frohman, Olaf Stüve, Eva Havrdova, et al.
Archives of Neurology|February 14, 2007
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventionsOlaf Stüve, Christina M Marra, Petra D Cravens, et al.
Archives of Neurology|July 14, 2010
Translational research in neurology and neuroscience 2010: multiple sclerosisOlaf Stüve, Bernd C Kieseier, Bernhard Hemmer, et al.
Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Annals of Neurology|August 19, 2007
Health-related quality of life in multiple sclerosis: effects of natalizumabRichard A Rudick, Deborah Miller, Steve Hass, et al.
Nature Communications|July 20, 2021
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome dataMatthew C Altman, Darawan Rinchai, Nicole Baldwin, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Archives of Neurology|October 12, 2005
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectationsElliot M Frohman, Olaf Stüve, Eva Havrdova, et al.
Archives of Neurology|February 14, 2007
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventionsOlaf Stüve, Christina M Marra, Petra D Cravens, et al.
Archives of Neurology|July 14, 2010
Translational research in neurology and neuroscience 2010: multiple sclerosisOlaf Stüve, Bernd C Kieseier, Bernhard Hemmer, et al.
Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Annals of Neurology|August 19, 2007
Health-related quality of life in multiple sclerosis: effects of natalizumabRichard A Rudick, Deborah Miller, Steve Hass, et al.
Nature Communications|July 20, 2021
Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome dataMatthew C Altman, Darawan Rinchai, Nicole Baldwin, et al.
Pageof 5